PJP
Invesco Dynamic Pharmaceuticals ETFPJP Fund Description
PJP tracks an index of US pharmaceutical companies selected and weighted based on various fundamental and risk factors.
PJP Factset Analytics Insight
PJP uses a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Although some of the major names are represented in the portfolio, PJP’s multifactor selection process tilts the fund toward mid and small-caps resulting in a low overall weighted average market cap, typically about half of our industry benchmark. Still, its small portfolio takes concentrated stakes in some leading names. Despite a hefty expense ratio and poor tracking in comparison to peers, PJP has attracted sizable AUM and trades easily at decent spreads.
PJP MSCI ESG Analytics Insight
Invesco Dynamic Pharmaceuticals ETF has an MSCI ESG Fund Rating of BBB based on a score of 5.15 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Invesco Dynamic Pharmaceuticals ETF ranks in the 42nd percentile within its peer group and in the 58th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
PJP Charts And Performance
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
PJP Summary Data
PJP Portfolio Data
PJP Portfolio Management
PJP Tax Exposures
PJP Fund Structure
PJP Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of PJP. PJP is rated a 5 out of 5.
PJP Tradability
PJP Sector/Industry Breakdown
PJP
PJP Top 10 Holdings[View All]
PJP Countries
PJP
PJP Regions
PJP
PJP Economic Development
PJP
PJP Performance Statistics
PJP MSCI ESG Ratings
PJP Benchmark Comparison Summary
PJP
PJP Benchmark Comparison Market Cap Size
PJP
The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.
ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.
[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
Data provider:
Terms of Use
MSCI ESG Research LLC’s ("MSCI ESG") Fund Metrics products (the "Information") provide environmental, social and governance data with respect to underlying securities within more than 24,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided "as is" and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.